| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 04/07/2005 | WO2005001778A3 Biologically active neopeltolide compounds |
| 04/07/2005 | WO2005000249A3 Preparation of chemical compounds |
| 04/07/2005 | WO2004062590A3 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| 04/07/2005 | WO2004039810A8 High purity phthalein derivatives and method for preparing same |
| 04/07/2005 | US20050075388 Compounds as viricides for treatment of HTLV or aids |
| 04/07/2005 | US20050074408 Compounds for fluorescent emission for animals |
| 04/07/2005 | CA2540186A1 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 04/06/2005 | EP1519910A1 Chiral dopant with phenylethanediol functionality |
| 04/06/2005 | EP1313690B1 Method of producing fluorinated and chlorinated benzaldehydes |
| 04/06/2005 | CN1604803A Combination of cytochome p450 dependent protease inhibitors |
| 04/05/2005 | US6875878 Chromene compound |
| 03/31/2005 | WO2005028482A1 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases |
| 03/31/2005 | WO2005028481A2 Fused pentacyclic polyethers |
| 03/31/2005 | WO2005028409A1 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds |
| 03/31/2005 | US20050070595 Complex of trioxane with iron compound |
| 03/31/2005 | US20050070579 Performing crystallization by using an organic solvent selected from a ketone solvent, a nitrile solvent, and a mixture thereof, or a mixture of organic solvent and water; acetone or acetonitrile can be preferably used as the organic solvent |
| 03/31/2005 | CA2539590A1 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases |
| 03/31/2005 | CA2539588A1 Fused pentacyclic polyethers |
| 03/30/2005 | EP1517997A2 Luminogenic protease substrates |
| 03/30/2005 | EP1517899A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 03/30/2005 | EP1345944B1 Process for the isolation and purification of epothilones |
| 03/30/2005 | CN1602192A Compositions comprising epothilones and their use for the treatment of carcinoid syndrome |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872841 Etoposide analogs and methods of use thereof |
| 03/29/2005 | US6872840 Anticancer agents |
| 03/24/2005 | WO2005026172A1 Prostamide receptor antagonists |
| 03/24/2005 | WO2004074249A3 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 03/24/2005 | WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 03/24/2005 | US20050065338 Total synthesis of galanthamine, analogues and derivatives thereof |
| 03/24/2005 | US20050065305 Superior in hole injecting property, making it unnecessary to add a strongly acidic dopant for enhancing hole injecting property; may be useful in flat panel display devices |
| 03/24/2005 | US20050065200 Prostaglandin EP4 antagonist |
| 03/24/2005 | US20050064308 Fluorescent probe for zinc |
| 03/23/2005 | EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | CN1599602A Peroxisome proliferator activated receptor ligands and process for producing the same |
| 03/17/2005 | WO2005023818A2 Heterobicyclic compounds as pharmaceutically active agents |
| 03/17/2005 | WO2005023817A1 9-amino-podophyllotoxin derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 03/17/2005 | WO2005023792A2 Macrocyclic compounds useful as pharmaceuticals |
| 03/17/2005 | US20050059832 Reacting a trimethylsilanylmethyl-allenol derivative by the intramolecular Prins cyclization using Lewis acid to synthesize 1-methyl-2,3-dimethylene-8-oxa-bicyclo[3.2.1]octane |
| 03/17/2005 | US20050059732 Synthesis of 8-membered carbocyclic compound having diexomethylene groups |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059612 Bicyclic carbohydrates as antiviral bioactives for the treatment of infections caused by the alphaherpesvirinae HSV-1 and HSV-2 |
| 03/17/2005 | CA2572750A1 Heterobicyclic compounds as pharmaceutically active agents |
| 03/17/2005 | CA2546823A1 9-amino-podophyllotoxin derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 03/16/2005 | EP1514844A1 Microporous crystalline zeolite material (zeolite itq-22), synthesis method thereof and use of same as a catalyst |
| 03/16/2005 | EP1513843A1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms |
| 03/16/2005 | CN1596259A Crystals of taxane derivative and process for their production |
| 03/16/2005 | CN1594319A Process for extracting ginkgolide, ginkgolide injection and process for preparing same |
| 03/16/2005 | CN1593406A Medicine for promoting wound healing |
| 03/16/2005 | CN1193030C Pyromellitic acid dianhydride trapping method |
| 03/16/2005 | CN1192999C Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors |
| 03/15/2005 | US6867333 Epothilone synthesis building blocks iii and iv: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones b, d and epothilone derivatives |
| 03/15/2005 | US6867321 Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof |
| 03/15/2005 | US6867296 Useful as a monomer in the manufacture of polymers and copolymers, especially polyester polymers and copolymers |
| 03/10/2005 | WO2005021496A2 Synthesis of derivatives of ginkgolide c |
| 03/10/2005 | WO2005020981A1 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | US20050054699 Skin disorders; vision defects; glandular disorders |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | US20050053557 Administering a lignan comprising 4-(phenyl)-furo/3*,4*:6,7/-naphtho/2,3-d/-1,3-dioxole derivative or plant extract |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/09/2005 | EP1511478A2 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 03/09/2005 | CN1592740A Process for the synthesis of amine ethers from secondary amino oxides and its use |
| 03/09/2005 | CN1592577A Anthelmintic composition |
| 03/09/2005 | CN1590388A Podophyllotoxin series derivative and its application |
| 03/09/2005 | CN1192031C Epothilones derivatives, their synthesis and uses |
| 03/08/2005 | US6864378 Forming isosorbide; reuse of high boiling by-products using aqueous solution |
| 03/08/2005 | US6864278 Antifungal agents of sordarin derivatives |
| 03/08/2005 | US6864265 Chemokine receptor binding heterocyclic compounds |
| 03/08/2005 | US6864073 Avermectin aglycon synthase genes |
| 03/03/2005 | WO2005019225A1 Process for producing compound having nk1 receptor antagonism and production intermediate thereof |
| 03/03/2005 | WO2005003085A3 Tajixanthone hydrate and tajixanthone hydrate derivatives, biological activities thereof, and use thereof |
| 03/03/2005 | US20050049300 Converting the carboxyl group of a thromboxane ligand to an amide or amine to obtain an ocular hypotensive agent; mimic the vasoconstrictor properties of thromboxane A2 and its endoperoxide precursors, without causing concomitant platelet aggregation; post-surgery and post laser treatment |
| 03/03/2005 | US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 03/03/2005 | US20050048135 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 03/02/2005 | EP1509222A1 Adduct of topiramate and tramadol hydrochloride and uses thereof |
| 03/02/2005 | EP1144416B1 Heterocyclically anellated indenochromene derivatives |
| 03/02/2005 | EP0948499B1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 03/02/2005 | CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 03/02/2005 | CN1589247A Method for preparing a composition containing at least an internal dehydrating product of a hydrogenated sugar |
| 03/02/2005 | CN1587266A Improved process for preparing podophyllotoxin from Chinese podophyllum root |
| 03/02/2005 | CN1586500A Disodium cantharidinate injection for treating tumor and its preparing method |
| 03/02/2005 | CN1191257C Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them |
| 03/02/2005 | CN1191256C Hexahydrofuro[2,3-B] furan-3-yl-N-{3-(1,3-benzodioxo1-5-ylsulfonyl) (isobutyl) Aminol-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor |
| 03/01/2005 | US6861564 Process for preparing resorcinol derivatives |
| 03/01/2005 | US6861537 Tricyclic and tetracyclic taxane intermediates |
| 02/24/2005 | WO2004094400A3 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 02/24/2005 | WO2004014960A3 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
| 02/24/2005 | US20050043549 Novel diterpene compounds |
| 02/24/2005 | US20050043376 Epothilone A and B; desoxyepothilone A and B; anticancer agenst |
| 02/24/2005 | US20050043308 Process for total synthesis of ecteinascidins and intermediates therefor |
| 02/24/2005 | DE10331500A1 Neue Acridin-Derivate und deren Verwendung als Arzneimittel New acridine derivatives and their use as medicaments |
| 02/24/2005 | DE10331004A1 Verfahren für die Herstellung von C1-C15-Fragmenten von Epothilonen und deren Derivaten A process for the preparation of C1-C15-fragments of epothilones and derivatives thereof |
| 02/23/2005 | EP1508345A1 Absorbents and devices for the reduction of small organic compounds from blood products |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1190440C Triazolo-epothilones |
| 02/22/2005 | US6858742 DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858732 Photochromic benzodioxine fused naphthopyran compounds, compositions and articles containing those naphthopyran compounds |